The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Cancer Inflammation and Cytokines
Open accessAbstract
Chronic inflammation is a well-recognized tumor-enabling capability, which allows nascent tumors to escape immunosurveillance. A number of soluble and cellular inflammatory mediators take part in the various phases of cancer initiation and progression, giving rise to a fatal conspiracy, which is difficult to efficiently overcome. Tumor-associated macrophages (TAMs) are pivotal players of the tumor microenvironment and, because of their characteristic plasticity, can acquire a number of distinct phenotypes and contribute in different ways to the various phases of cancerogenesis. Tumor-associated neutrophils (TANs) are also emerging as important components of the tumor microenvironment, given their unexpected heterogeneity and plasticity. TAMs and TANs are both integrated in cancer-related inflammation and an ever better understanding of their functions can be useful to tailor the use of anticancer therapeutic approaches and patient follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Self-citationImmunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Self-citationMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Self-citationCancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 2×
“Indeed, even if the presence of an immune infiltrate in and around the tumors was already knownfora longtime(Dvorak1986), itwas largely attributed to an effort of the immune system to combat tumors.”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Neutrophils in the activation and regulation of innate and adaptive immunity
Mantovani, A., Cassatella, M. A., Costantini, C., & Jaillon, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3024 · Cited by 3,027
Self-citationCSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Macrophage plasticity and polarization in tissue repair and remodelling
Mantovani, A., Biswas, S. K., Galdiero, M. R., Sica, A., & Locati, M. (2013) · The Journal of Pathology · doi:10.1002/path.4133 · Cited by 2,384 · cited 1×
“M2 macrophages produce low levels of IL-12 and are mainly involved in immunoregulatory networks, regulating tissue remodeling, and angiogenesis (Mantovani et al. 2013).”
BackgroundSelf-citationNoman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
DeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer
Guthrie, G. J. K., Charles, K. A., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Clarke, S. J. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.010 · Cited by 1,552
Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis
Cools-Lartigue, J., Spicer, J., McDonald, B., Gowing, S., Chow, S., Giannias, B., Bourdeau, F., Kubes, P., & Ferri, L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67484 · Cited by 1,395
Ries, C. H., Cannarile, M. A., Hoves, S., Benz, J., Wartha, K., Runza, V., Rey-Giraud, F., Pradel, L. P., Feuerhake, F., Klaman, I., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.016 · Cited by 1,384
Jenkins, S. J., Ruckerl, D., Cook, P. C., Jones, L. H., Finkelman, F. D., van Rooijen, N., MacDonald, A. S., & Allen, J. E. (2011) · Science · doi:10.1126/science.1204351 · Cited by 1,366
Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stangé, G., Van den Bossche, J., Mack, M., Pipeleers, D., In't Veld, P., De Baetselier, P., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4672 · Cited by 1,239
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J.-L., Gorbatov, R., Sukhova, G. K., Gerhardt, L. M. S., Smyth, D., et al. (2013) · Nature Medicine · doi:10.1038/nm.3258 · Cited by 1,041
Zhang, Q.-W., Liu, L., Gong, C.-Y., Shi, H.-S., Zeng, Y.-H., Wang, X.-Z., Zhao, Y.-W., & Wei, Y.-Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050946 · Cited by 1,039
Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
Stylianopoulos, T., Martin, J. D., Chauhan, V. P., Jain, S. R., Diop-Frimpong, B., Bardeesy, N., Smith, B. L., Ferrone, C. R., Hornicek, F. J., Boucher, Y., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213353109 · Cited by 943
Nozawa, H., Chiu, C., & Hanahan, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601807103 · Cited by 923
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867
Differential macrophage programming in the tumor microenvironment
Ruffell, B., Affara, N. I., & Coussens, L. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.12.001 · Cited by 860
New insights into the multidimensional concept of macrophage ontogeny, activation and function
Ginhoux, F., Schultze, J. L., Murray, P. J., Ochando, J., & Biswas, S. K. (2016) · Nature Immunology · doi:10.1038/ni.3324 · Cited by 833
Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
Sagiv, J. Y., Michaeli, J., Assi, S., Mishalian, I., Kisos, H., Levy, L., Damti, P., Lumbroso, D., Polyansky, L., Sionov, R. V., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2014.12.039 · Cited by 816
Tumor entrained neutrophils inhibit seeding in the premetastatic lung
Granot, Z., Henke, E., Comen, E. A., King, T. A., Norton, L., & Benezra, R. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.012 · Cited by 782
Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 747
Neutrophil elastase–mediated degradation of IRS-1 accelerates lung tumor growth
Houghton, A. M., Rzymkiewicz, D. M., Ji, H., Gregory, A. D., Egea, E. E., Metz, H. E., Stolz, D. B., Land, S. R., Marconcini, L. A., Kliment, C. R., et al. (2010) · Nature Medicine · doi:10.1038/nm.2084 · Cited by 744
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
Wang, L., Rubinstein, R., Lines, J. L., Wasiuk, A., Ahonen, C., Guo, Y., Lu, L.-F., Gondek, D., Wang, Y., Fava, R. A., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100619 · Cited by 710
Denny, M. F., Yalavarthi, S., Zhao, W., Thacker, S. G., Anderson, M., Sandy, A. R., McCune, W. J., & Kaplan, M. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902199 · Cited by 701
Ma, Y., Adjemian, S., Mattarollo, S. R., Yamazaki, T., Aymeric, L., Yang, H., Portela Catani, J. P., Hannani, D., Duret, H., Steegh, K., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.003 · Cited by 699
Origins of tumor-associated macrophages and neutrophils
Cortez-Retamozo, V., Etzrodt, M., Newton, A., Rauch, P. J., Chudnovskiy, A., Berger, C., Ryan, R. J. H., Iwamoto, Y., Marinelli, B., Gorbatov, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113744109 · Cited by 689
Ethier, J.-L., Desautels, D., Templeton, A., Shah, P. S., & Amir, E. (2017) · Breast Cancer Research · doi:10.1186/s13058-016-0794-1 · Cited by 673
The secret ally: immunostimulation by anticancer drugs
Galluzzi, L., Senovilla, L., Zitvogel, L., & Kroemer, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3626 · Cited by 670
Kitamura, T., Qian, B.-Z., Soong, D., Cassetta, L., Noy, R., Sugano, G., Kato, Y., Li, J., & Pollard, J. W. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141836 · Cited by 651
The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00607.x · Cited by 651
Self-citationChemokines and chemokine receptors: new insights into cancer-related inflammation
Lazennec, G., & Richmond, A. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.01.003 · Cited by 650
Bv8 regulates myeloid-cell-dependent tumour angiogenesis
Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.-H., Yao, J., Blanchard, D., Bais, C., Peale, F. V., van Bruggen, N., et al. (2007) · Nature · doi:10.1038/nature06348 · Cited by 644
Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
Eruslanov, E. B., Bhojnagarwala, P. S., Quatromoni, J. G., Stephen, T. L., Ranganathan, A., Deshpande, C., Akimova, T., Vachani, A., Litzky, L., Hancock, W. W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci77053 · Cited by 644
Myeloid-derived suppressor cell heterogeneity and subset definition
Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., & Bronte, V. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.021 · Cited by 630
Ardi, V. C., Kupriyanova, T. A., Deryugina, E. I., & Quigley, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706438104 · Cited by 602
Tumor associated macrophages and neutrophils in cancer
Galdiero, M. R., Bonavita, E., Barajon, I., Garlanda, C., Mantovani, A., & Jaillon, S. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.06.003 · Cited by 597
Self-citationButowski, N., Colman, H., De Groot, J. F., Omuro, A. M., Nayak, L., Wen, P. Y., Cloughesy, T. F., Marimuthu, A., Haidar, S., Perry, A., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov245 · Cited by 593
Jablonska, J., Leschner, S., Westphal, K., Lienenklaus, S., & Weiss, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci37223 · Cited by 564
Liang, J., Nagahashi, M., Kim, E. Y., Harikumar, K. B., Yamada, A., Huang, W.-C., Hait, N. C., Allegood, J. C., Price, M. M., Avni, D., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.013 · Cited by 563
The impact of hypoxia on tumor-associated macrophages
Henze, A.-T., & Mazzone, M. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84427 · Cited by 546
Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy
Hughes, R., Qian, B.-Z., Rowan, C., Muthana, M., Keklikoglou, I., Olson, O. C., Tazzyman, S., Danson, S., Addison, C., Clemons, M., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3587 · Cited by 518
Buddingh, E. P., Kuijjer, M. L., Duim, R. A. J., Bürger, H., Agelopoulos, K., Myklebost, O., Serra, M., Mertens, F., Hogendoorn, P. C. W., Lankester, A. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2047 · Cited by 508
Kuang, D.-M., Zhao, Q., Wu, Y., Peng, C., Wang, J., Xu, Z., Yin, X.-Y., & Zheng, L. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.08.041 · Cited by 499
Shojaei, F., Wu, X., Qu, X., Kowanetz, M., Yu, L., Tan, M., Meng, Y. G., & Ferrara, N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902280106 · Cited by 471
Jensen, H. K., Donskov, F., Marcussen, N., Nordsmark, M., Lundbeck, F., & von der Maase, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9498 · Cited by 461
Tumor associated macrophages and neutrophils in tumor progression
Galdiero, M. R., Garlanda, C., Jaillon, S., Marone, G., & Mantovani, A. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24260 · Cited by 440
Self-citationNovel Lipid Mediators and Resolution Mechanisms in Acute Inflammation
Serhan, C. N. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100322 · Cited by 421
Queen, M. M., Ryan, R. E., Holzer, R. G., Keller-Peck, C. R., & Jorcyk, C. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1734 · Cited by 413
Pienta, K. J., Machiels, J.-P., Schrijvers, D., Alekseev, B., Shkolnik, M., Crabb, S. J., Li, S., Seetharam, S., Puchalski, T. A., Takimoto, C., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9869-8 · Cited by 412
De Larco, J. E., Wuertz, B. R. K., & Furcht, L. T. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0760 · Cited by 412
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis
Jamieson, T., Clarke, M., Steele, C. W., Samuel, M. S., Neumann, J., Jung, A., Huels, D., Olson, M. F., Das, S., Nibbs, R. J. B., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61067 · Cited by 391
Allavena, P., & Mantovani, A. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04515.x · Cited by 384
Self-citationHuh, S. J., Liang, S., Sharma, A., Dong, C., & Robertson, G. P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4442 · Cited by 352
Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression
Shojaei, F., Singh, M., Thompson, J. D., & Ferrara, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712185105 · Cited by 334
Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancer
Ramsey, S., Lamb, G. W. A., Aitchison, M., Graham, J., & McMillan, D. C. (2007) · Cancer · doi:10.1002/cncr.22400 · Cited by 334
Loberg, R. D., Ying, C., Craig, M., Day, L. L., Sargent, E., Neeley, C., Wojno, K., Snyder, L. A., Yan, L., & Pienta, K. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1286 · Cited by 333
Rao, H.-L., Chen, J.-W., Li, M., Xiao, Y.-B., Fu, J., Zeng, Y.-X., Cai, M.-Y., & Xie, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030806 · Cited by 327
Fridlender, Z. G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W., Fridlender, G., Bayuh, R., Worthen, G. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031524 · Cited by 311
Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer
Keane, M. P., Belperio, J. A., Xue, Y. Y., Burdick, M. D., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2853 · Cited by 305
Bekes, E. M., Schweighofer, B., Kupriyanova, T. A., Zajac, E., Ardi, V. C., Quigley, J. P., & Deryugina, E. I. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.031 · Cited by 298
Immunomonitoring and prognostic relevance of neutrophils in clinical trials
Donskov, F. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.02.001 · Cited by 293
Genotoxic effects of neutrophils and hypochlorous acid
Gungor, N., Knaapen, A. M., Munnia, A., Peluso, M., Haenen, G. R., Chiu, R. K., Godschalk, R. W. L., & van Schooten, F. J. (2010) · Mutagenesis · doi:10.1093/mutage/gep053 · Cited by 291
Prognostic value of tumor‐associated macrophage count in human bladder cancer
Hanada, T., Nakagawa, M., Emoto, A., Nomura, T., Nasu, N., & Nomura, Y. (2000) · International Journal of Urology · doi:10.1046/j.1442-2042.2000.00190.x · Cited by 283
Trellakis, S., Bruderek, K., Dumitru, C. A., Gholaman, H., Gu, X., Bankfalvi, A., Scherag, A., Hütte, J., Dominas, N., Lehnerdt, G. F., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25892 · Cited by 281
Weizman, N., Krelin, Y., Shabtay-Orbach, A., Amit, M., Binenbaum, Y., Wong, R. J., & Gil, Z. (2014) · Oncogene · doi:10.1038/onc.2013.357 · Cited by 281
Kryczek, I., Wei, S., Zou, L., Zhu, G., Mottram, P., Xu, H., Chen, L., & Zou, W. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.40 · Cited by 277
Di Caro, G., Cortese, N., Castino, G. F., Grizzi, F., Gavazzi, F., Ridolfi, C., Capretti, G., Mineri, R., Todoric, J., Zerbi, A., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-309193 · Cited by 275
Self-citationSandhu, S. K., Papadopoulos, K., Fong, P. C., Patnaik, A., Messiou, C., Olmos, D., Wang, G., Tromp, B. J., Puchalski, T. A., Balkwill, F., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2099-8 · Cited by 272
Campbell, M. J., Tonlaar, N. Y., Garwood, E. R., Huo, D., Moore, D. H., Khramtsov, A. I., Au, A., Baehner, F., Chen, Y., Malaka, D. O., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1154-y · Cited by 270
Antitumor and Anti-inflammatory Effects of Trabectedin on Human Myxoid Liposarcoma Cells
Germano, G., Frapolli, R., Simone, M., Tavecchio, M., Erba, E., Pesce, S., Pasqualini, F., Grosso, F., Sanfilippo, R., Casali, P. G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2335 · Cited by 267
Self-citationCXC Chemokines in Cancer Angiogenesis and Metastases
(2010) · Advances in Cancer Research · doi:10.1016/s0065-230x(10)06003-3 · Cited by 263
Lu, X., & Kang, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.035899 · Cited by 257
Ijichi, H., Chytil, A., Gorska, A. E., Aakre, M. E., Bierie, B., Tada, M., Mohri, D., Miyabayashi, K., Asaoka, Y., Maeda, S., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42754 · Cited by 256 · cited 1×
“For instance, murine models showed a central role for CXCR2 in promoting lung and pancreatic cancers (Keane et al. 2004; Ijichi et al. 2011).”
BackgroundScapini, P., Morini, M., Tecchio, C., Minghelli, S., Di Carlo, E., Tanghetti, E., Albini, A., Lowell, C., Berton, G., Noonan, D. M., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.5034 · Cited by 249
Wislez, M., Rabbe, N., Marchal-Sommé, J., Milleron, B. J., Crestani, B., Mayaud, C. M., Antoine, M., Soler, P., & Cadranel, J. L. (2003) · PubMed · Cited by 243
Mismatch repair deficient colorectal cancer in the era of personalized treatment
Hewish, M., Lord, C. J., Martin, S. A., Cunningham, D., & Ashworth, A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.18 · Cited by 235
Davies, L. C., Rosas, M., Smith, P. J., Fraser, D. J., Jones, S. A., & Taylor, P. R. (2011) · European Journal of Immunology · doi:10.1002/eji.201141817 · Cited by 228
Neutrophil infiltration into human gliomas
Fossati, G., Ricevuti, G., Edwards, S. W., Walker, C., Dalton, A., & Rossi, M. L. (1999) · Acta Neuropathologica · doi:10.1007/s004010051093 · Cited by 227
Brana, I., Calles, A., LoRusso, P. M., Yee, L. K., Puchalski, T. A., Seetharam, S., Zhong, B., de Boer, C. J., Tabernero, J., & Calvo, E. (2015) · Targeted Oncology · doi:10.1007/s11523-014-0320-2 · Cited by 216
Bornstein, S., White, R., Malkoski, S., Oka, M., Han, G., Cleaver, T., Reh, D., Andersen, P., Gross, N., Olson, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38854 · Cited by 215
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer
Murri, A. M. A., Bartlett, J. M. S., Canney, P. A., Doughty, J. C., Wilson, C., & McMillan, D. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602922 · Cited by 211
Caruso, R. A., Bellocco, R., Pagano, M., Bertoli, G., Rigoli, L., & Inferrera, C. (2002) · Modern Pathology · doi:10.1097/01.mp.0000020391.98998.6b · Cited by 194
Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer
Galdiero, M. R., Bianchi, P., Grizzi, F., Di Caro, G., Basso, G., Ponzetta, A., Bonavita, E., Barbagallo, M., Tartari, S., Polentarutti, N., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30076 · Cited by 192
Self-citationLutgens, E. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00311-3 · Cited by 183
Distinct Functions of Neutrophil in Cancer and Its Regulation
Granot, Z., & Jablonska, J. (2015) · Mediators of Inflammation · doi:10.1155/2015/701067 · Cited by 179
Tumor-infiltrating neutrophils in pancreatic neoplasia
Reid, M. D., Basturk, O., Thirabanjasak, D., Hruban, R. H., Klimstra, D. S., Bagci, P., Altinel, D., & Adsay, V. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.113 · Cited by 177
Ohno, S., Inagawa, H., Dhar, D. K., Fujii, T., Ueda, S., Tachibana, M., Suzuki, N., Inoue, M., Soma, G., & Nagasue, N. (2003) · PubMed · Cited by 171
Tecchio, C., Huber, V., Scapini, P., Calzetti, F., Margotto, D., Todeschini, G., Pilla, L., Martinelli, G., Pizzolo, G., Rivoltini, L., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2806 · Cited by 162
The Yin-Yang of Tumor-Associated Neutrophils
Mantovani, A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.014 · Cited by 153
Self-citationFridlender, Z. G., Kapoor, V., Buchlis, G., Cheng, G., Sun, J., Wang, L. S., Singhal, S. K., Snyder, L. A., & Albelda, S. Μ. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0080oc · Cited by 151
The diversity of circulating neutrophils in cancer
Mishalian, I., Granot, Z., & Fridlender, Z. G. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.02.001 · Cited by 146
Dumitru, C. A., Gholaman, H., Trellakis, S., Bruderek, K., Dominas, N., Gu, X., Bánkfalvi, Á., Whiteside, T. L., Lang, S., & Brandau, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.25991 · Cited by 142
Große-Steffen, T., Giese, T., Giese, N. A., Longerich, T., Schirmacher, P., Hänsch, G. M., & Gaida, M. M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/720768 · Cited by 138
Kridel, R., Xerri, L., Gelas‐Dore, B., Tan, K. L., Feugier, P., Vawda, A., Canioni, D., Farinha, P., Boussetta, S., Moccia, A. A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3253 · Cited by 132
Kemp, T. J., Ludwig, A. T., Earel, J. K., Moore, J. M., VanOosten, R. L., Moses, B., Leidal, K. G., Nauseef, W. M., & Griffith, T. S. (2005) · Blood · doi:10.1182/blood-2005-03-1327 · Cited by 129
Cloke, T., Munder, M., Taylor, G. P., Müller, I., & Kropf, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048939 · Cited by 125
Granata, F., Frattini, A., Loffredo, S., Staiano, R. I., Petraroli, A., Ribatti, D., Oslund, R., Gelb, M. H., Lambeau, G. J., Marone, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902501 · Cited by 124
Self-citationEnhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers
Moisan, F., Francisco, E. B., Brozović, A., Durán, G. E., Wang, Y. C., Chaturvedi, S., Seetharam, S., Snyder, L. A., Doshi, P. D., & Sikic, B. I. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.016 · Cited by 122
Droeser, R. A., Hirt, C., Eppenberger‐Castori, S., Zlobec, I., Viehl, C. T., Frey, D. M., Nebiker, C. A., Rosso, R., Zuber, M., Amicarella, F., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064814 · Cited by 119
Barash, H., Gross, E. R., Edrei, Y., Ella, E., Israel, A., Cohen, I., Corchia, N., Ben-Moshe, T., Pappo, O., Pikarsky, E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908867107 · Cited by 119
Hotchkiss, K. A., Ashton, A. W., Klein, R. S., Lenzi, M. L., Zhu, G. H., & Schwartz, E. L. (2003) · PubMed · Cited by 115
Manthey, C. L., Johnson, D. L., Illig, C. R., Tuman, R. W., Zhao, Z., Baker, J. F., Chaikin, M. A., Donatelli, R. R., Franks, C. F., Zeng, L., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0255 · Cited by 115
Watanabe, M., Kato, J., Inoue, I., Yoshimura, N., Yoshida, T., Mukoubayashi, C., Deguchi, H., Enomoto, S., Ueda, K., Maekita, T., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27514 · Cited by 109
Value of pH regulators in the diagnosis, prognosis and treatment of cancer
Granja, S., Tavares‐Valente, D., Queirós, O., & Baltazar, F. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.12.003 · Cited by 109
Schmidt, T., & Carmeliet, P. (2010) · Nature · doi:10.1038/465697a · Cited by 108
Phagocytes as Corrupted Policemen in Cancer-Related Inflammation
Bonavita, E., Galdiero, M. R., Jaillon, S., & Mantovani, A. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2015.04.013 · Cited by 102
Self-citationInflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer
Leifler, K. S., Svensson, S., Abrahamsson, A. E., Bendrik, C., Robertson, J. V., Gauldie, J., Olsson, A., & Dabrosin, C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202610 · Cited by 97
Lymphatic Vessels, Inflammation, and Immunity in Skin Cancer
Lund, A. W., Medler, T. R., Leachman, S. A., & Coussens, L. M. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0023 · Cited by 97
Liguori, M., Buracchi, C., Pasqualini, F., Bergomas, F., Pesce, S., Sironi, M., Grizzi, F., Mantovani, A., Belgiovine, C., & Allavena, P. (2016) · Oncotarget · doi:10.18632/oncotarget.9340 · Cited by 94
Self-citationMittendorf, E. A., Alatrash, G., Qiao, N., Wu, Y., Sukhumalchandra, P., John, L. S. S., Philips, A. V., Xiao, H., Zhang, M., Ruisaard, K. E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4135 · Cited by 91
CXCL17 Expression by Tumor Cells Recruits CD11b+Gr1highF4/80− Cells and Promotes Tumor Progression
Matsui, A., Yokoo, H., Negishi, Y., Endo‐Takahashi, Y., Chun, N. A. L., Kadouchi, I., Suzuki, R., Maruyama, K., Aramaki, Y., Semba, K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044080 · Cited by 86
Colombo, N., Peccatori, F. A., Paganin, C., Bini, S., Brandely, M., Mangioni, C., Mantovani, A., & Allavena, P. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510109 · Cited by 79
Self-citationControversial role of mast cells in skin cancers
Varricchi, G., Galdiero, M. R., Marone, G., Granata, F., Borriello, F., & Marone, G. (2016) · Experimental Dermatology · doi:10.1111/exd.13107 · Cited by 77
Self-citationNie, W., Yu, T., Sang, Y., & Gao, X. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.12.048 · Cited by 74
Sun, X., Glynn, D. J., Hodson, L. J., Huo, C. W., Britt, K. L., Thompson, E. W., Woolford, L., Evdokiou, A., Pollard, J. W., Robertson, S. A., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-016-0796-z · Cited by 74
Wang, J., Hu, W., Wang, K., Yu, J., Luo, B., Luo, G., Wang, W., Wang, H., Li, J., & Wen, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3371 · Cited by 73
Bottazzi, B., Erba, E., Nobili, N., Fazioli, F., Rambaldi, A., & Mantovani, A. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.6.2409 · Cited by 62
Self-citationA novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer
Dumitru, C. A., Fechner, M. K., Hoffmann, T. K., Lang, S., & Brandau, S. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0411193 · Cited by 61
A New VISTA on combination therapy for negative checkpoint regulator blockade
Deng, J., Mercier, I. L., Kuta, A., & Noelle, R. J. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0190-5 · Cited by 55
On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils
Cassatella, M. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005558 · Cited by 53
Angiogenic activity of bFGF and VEGF suppressed by proteolytic cleavage by neutrophil elastase
Ai, S., Cheng, X. W., Inoue, A., Nakamura, K., Okumura, K., Iguchi, A., Murohara, T., & Kuzuya, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.027 · Cited by 50
Inhibition of Neutrophil Elastase Suppresses the Development of Skin Tumors in Hairless Mice
STARCHER, B. C., O’Neal, P., Granstein, R. D., & Beissert, S. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12329559 · Cited by 49
Shen, J., Zhu, Y., Wu, W., Zhang, L., Ju, H., Fan, Y., Zhu, Y., Luo, J., Liu, P., Zhou, N., et al. (2017) · Medical Science Monitor · doi:10.12659/msm.902752 · Cited by 45
Tanaka, H., Ito, T., Kyo, T., & Kimura, A. (2007) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2007.00834.x · Cited by 32
Nawa, M., Osada, S., Morimitsu, K., Nonaka, K., Futamura, M., Kawaguchi, Y., & Yoshida, K. (2012) · PubMed · Cited by 30
Neutrophils Activate Tumoral CORTACTIN to Enhance Progression of Orohypopharynx Carcinoma
Dumitru, C. A., Bánkfalvi, Á., Gu, X., Eberhardt, W., Zeidler, R., Lang, S., & Brandau, S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00033 · Cited by 30
Nakamura, K., Yoshida, N., Baba, Y., Kosumi, K., Uchihara, T., Kiyozumi, Y., Ohuchi, M., Ishimoto, T., Iwatsuki, M., Sakamoto, Y., et al. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1090-5 · Cited by 28
Could B7-H4 serve as a target to activate anti-cancer immunity?
Wang, L., Heng, X., Lu, Y., Cai, Z., Yi, Q., & Che, F. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.05.020 · Cited by 22
Zhang, Y., Wang, J., Wang, W., Tian, J., Yin, K., Tang, X., Ma, J., Xu, H., & Wang, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-5414-2 · Cited by 21
Caro, G. D., Marchesi, F., Galdiero, M. R., & Grizzi, F. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2014.900443 · Cited by 6
Self-citation
Cited by
The evolving translational potential of small extracellular vesicles in cancer
Möller, A., & Lobb, R. J. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00299-w · Cited by 544
Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis
Bajaj, R., Warner, A. N., Fradette, J. F., & Gibbons, D. L. (2022) · Cells · doi:10.3390/cells11091484 · Cited by 74
Metadata
- Authors
- Galdiero, M. R., Marone, G., & Mantovani, A.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2017-08-04
- Volume
- 10
- Issue
- 8
- Pages
- a028662
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2744617457
- Cited by
- 267
- References
- 146
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.